{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:41:31Z","timestamp":1753922491911,"version":"3.41.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Phys Med Rehabil"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Intramuscular botulinum toxin A (BTX-A) is used in the management of focal spasticity in cerebral palsy (CP). The aim was to conduct a systematic review to assess current literature on the use of BTX-A in the management of mobility-related outcomes among adult persons with spastic CP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All studies reporting on the use of BTX-A in the management of spastic CP among adult persons were identified by searching the following electronic databases: PubMed, CINAHL, the Cochrane Library, and EMBASE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Six studies were included in the review. Most studies were conducted in mixed patient groups comprising patients with movement disorders, traumatic brain injury, CP, and other disorders requiring therapy for spasticity. BTX-A was shown to be effective in improving spasticity-related outcomes among persons with CP, but mixed results were shown for functional outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>More studies are required on exclusive CP cohorts using recommended and currently used scales, incorporating quality of life and patient satisfaction scales. Results from long-term follow-up studies will be valuable for better evaluation of the effectiveness of BTX-A in the management of spasticity-related outcomes among adult persons with CP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/phm.0000000000001653","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T20:13:23Z","timestamp":1606767203000},"page":"851-857","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of Botulinum Toxin A Injection in Managing Mobility-Related Outcomes in Adult Patients With Cerebral Palsy"],"prefix":"10.1097","volume":"100","author":[{"given":"Nalinda D.","family":"Andraweera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabha H.","family":"Andraweera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohra S.","family":"Lassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venugopal","family":"Kochiyil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"bib1-20250616","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ridd.2018.06.012","article-title":"Systematic review of the economic impact of cerebral palsy","volume":"80","year":"2018","journal-title":"Res Dev Disabil"},{"key":"bib2-20250616","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3109\/09638288.2014.883443","article-title":"Effect of multisite botulinum toxin injections on gait quality in adults with cerebral palsy","volume":"36","year":"2014","journal-title":"Disabil Rehabil"},{"key":"bib3-20250616","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/16501970500415348","article-title":"Focal spasticity therapy with botulinum toxin: Effects on function, activities of daily living and pain in 100 adult patients","volume":"38","year":"2006","journal-title":"J Rehabil Med"},{"key":"bib4-20250616","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/cch.12549","article-title":"Are the health needs of young people with cerebral palsy met during transition from child to adult health care?","volume":"44","year":"2018","journal-title":"Child Care Health Dev"},{"key":"bib5-20250616","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.apmr.2007.04.018","article-title":"What do we really know about the transition to adult-centered health care? A focus on cerebral palsy and spina bifida","volume":"88","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"bib6-20250616","first-page":"279175","article-title":"Clinical understanding of spasticity: Implications for practice","volume":"2014","year":"2014","journal-title":"Rehabil Res Pract"},{"key":"bib7-20250616","doi-asserted-by":"crossref","first-page":"e0119","DOI":"10.2106\/JBJS.RVW.19.00119","article-title":"Botulinum toxin A injection in treatment of upper limb spasticity in children with cerebral palsy: a systematic review of randomized controlled trials","volume":"8","year":"2020","journal-title":"JBJS Rev"},{"key":"bib8-20250616","first-page":"CD001408","article-title":"Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy","volume":"10","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"bib9-20250616","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.2010.01354.x","article-title":"Efficacy and safety of NT 201 for upper limb spasticity of various etiologies\u2014A randomized parallel-group study","volume":"122","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"bib10-20250616","first-page":"515","article-title":"High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy","volume":"34","year":"2014","journal-title":"NeuroRehabilitation"},{"key":"bib11-20250616","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2340\/16501977-0672","article-title":"Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial","volume":"43","year":"2011","journal-title":"J Rehabil Med"},{"key":"bib12-20250616","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp.69.4.499","article-title":"Evaluating the role of botulinum toxin in the management of focal hypertonia in adults","volume":"69","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib13-20250616","first-page":"165","article-title":"Health care services for adults with cerebral palsy","volume":"39","year":"2010","journal-title":"Aust Fam Physician"},{"key":"bib14-20250616","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0003-9993(99)90053-9","article-title":"Reliability of the tone assessment scale and the Modified Ashworth Scale as clinical tools for assessing poststroke spasticity","volume":"80","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"key":"bib15-20250616","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.apmr.2009.11.017","article-title":"Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy","volume":"91","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"bib16-20250616","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.apmr.2013.06.026","article-title":"Intra- and interrater reliability of the Modified Tardieu Scale for the assessment of lower limb spasticity in adults with neurologic injuries","volume":"94","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"bib17-20250616","first-page":"383","article-title":"Change in mobility function and its causes in adults with cerebral palsy by Gross Motor Function Classification System level: A cross-sectional questionnaire study","volume":"42","year":"2018","journal-title":"NeuroRehabilitation"},{"key":"bib18-20250616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09638288.2013.775359","article-title":"Gait function and decline in adults with cerebral palsy: a systematic review","volume":"36","year":"2014","journal-title":"Disabil Rehabil"},{"issue":"Suppl 2","key":"bib19-20250616","first-page":"9","article-title":"Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement","volume":"17","year":"2010","journal-title":"Eur J Neurol"},{"issue":"pt A","key":"bib20-20250616","first-page":"64","article-title":"Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them","volume":"107","year":"2015","journal-title":"Toxicon"},{"key":"bib21-20250616","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/1658-354X.121087","article-title":"Spasticity\u2014Pathogenesis, prevention and treatment strategies","volume":"7","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"bib22-20250616","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/0883073810362266","article-title":"Evaluation of spasticity in children with cerebral palsy using Ashworth and Tardieu scales compared with laboratory measures","volume":"25","year":"2010","journal-title":"J Child Neurol"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000001653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T21:13:22Z","timestamp":1750108402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000001653"}},"subtitle":["Systematic Review"],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000001653","relation":{},"ISSN":["1537-7385","0894-9115"],"issn-type":[{"type":"electronic","value":"1537-7385"},{"type":"print","value":"0894-9115"}],"subject":[],"published":{"date-parts":[[2020,11,30]]}}}